Grand Rounds July 8, 2022: Results From the COVID-OUT Trial, A Phase-3 Trial of Outpatient Treatment for Covid-19 Using Metformin, Ivermectin, and Fluvoxamine (Carolyn Bramante, MD, MPH; Thomas Murray, PhD; Jared Huling, PhD)
Rethinking Clinical Trials
AUGUST 22, 2022
Core Faculty, Center for Pediatric Obesity Medicine. The dosing for the drugs during the trial was Ivermectin 390 (470mcg/kg/day x 3 days), Metformin titration to 1,500mg/day over 7 days, and Fluvoxamine 50mg. ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ?. Speakers. Carolyn Bramante, MD, MPH. University of Minnesota Medical School. Key Points.
130 
Let's personalize your content